You are here: Industry Insights > MATRIX

News List

GentiBio raises $157m to develop Treg therapies for autoimmune diseases pharmaceutical-technology
August 13, 2021
GentiBio has raised $157m in a Series A funding round led by Matrix Capital Management to progress its new pipeline of engineered regulatory T cell (Treg) treatments in immunology.
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE prnasia
June 25, 2021
Triastek, Inc., a global leader in 3D printed pharmaceuticals, has completed its Series B financing, raising US$ 50 million (RMB 330 million).
Matrix Collaborates with AstraZeneca on Trial for COVID-19 Long-Acting Antibody Combination americanpharmaceuticalreview
February 09, 2021
Matrix Medical Network® announced a collaboration with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB) combination for the potential prevention of COVID-19.
Cellect, denovoMATRIX start stem cell research project fiercebiotech
July 09, 2018
Cellect Biotechnology and a group at Technische Universität Dresden (TU Dresden) have teamed upto explore the combination of their stem cell technologies.